WallStreetZenWallStreetZen

NASDAQ: BMRA
Biomerica Inc Stock

$1.23-0.02 (-1.6%)
Updated Feb 28, 2024
BMRA Price
$1.23
Fair Value Price
N/A
Market Cap
$20.69M
52 Week Low
$0.70
52 Week High
$2.78
P/E
-3.24x
P/B
2.21x
P/S
2.85x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.50M
Earnings
-$6.08M
Gross Margin
16.1%
Operating Margin
-109.14%
Profit Margin
-110.6%
Debt to Equity
0.26
Operating Cash Flow
-$5M
Beta
-0.32
Next Earnings
Apr 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BMRA Overview

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BMRA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BMRA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BMRA is good value based on its book value relative to its share price (2.21x), compared to the US Medical Devices industry average (4x)
P/B vs Industry Valuation
BMRA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BMRA due diligence checks available for Premium users.

Be the first to know about important BMRA news, forecast changes, insider trades & much more!

BMRA News

Valuation

BMRA fair value

Fair Value of BMRA stock based on Discounted Cash Flow (DCF)
Price
$1.23
Fair Value
$1.46
Undervalued by
15.93%
BMRA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BMRA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.24x
Industry
32.47x
Market
35.52x

BMRA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.21x
Industry
4x
BMRA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BMRA's financial health

Profit margin

Revenue
$1.6M
Net Income
-$1.5M
Profit Margin
-96.2%
BMRA's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
BMRA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.8M
Liabilities
$2.4M
Debt to equity
0.26
BMRA's short-term assets ($10.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BMRA's short-term assets ($10.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BMRA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BMRA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$842.0k
Investing
-$12.0k
Financing
$0.0
BMRA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BMRA vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
BMRA$20.69M-1.60%-3.24x2.21x
PETV$18.95M-4.24%-1.31x21.17x
NRXS$18.25M0.00%-0.90x-17.20x
SSKN$17.87M+1.59%-2.55x1.10x
IINN$17.87M-1.32%-1.57x2.37x

Biomerica Stock FAQ

What is Biomerica's quote symbol?

(NASDAQ: BMRA) Biomerica trades on the NASDAQ under the ticker symbol BMRA. Biomerica stock quotes can also be displayed as NASDAQ: BMRA.

If you're new to stock investing, here's how to buy Biomerica stock.

What is the 52 week high and low for Biomerica (NASDAQ: BMRA)?

(NASDAQ: BMRA) Biomerica's 52-week high was $2.78, and its 52-week low was $0.70. It is currently -55.76% from its 52-week high and 74.72% from its 52-week low.

How much is Biomerica stock worth today?

(NASDAQ: BMRA) Biomerica currently has 16,821,646 outstanding shares. With Biomerica stock trading at $1.23 per share, the total value of Biomerica stock (market capitalization) is $20.69M.

Biomerica stock was originally listed at a price of $2.97 in Aug 29, 2016. If you had invested in Biomerica stock at $2.97, your return over the last 7 years would have been -58.59%, for an annualized return of -11.83% (not including any dividends or dividend reinvestments).

How much is Biomerica's stock price per share?

(NASDAQ: BMRA) Biomerica stock price per share is $1.23 today (as of Feb 28, 2024).

What is Biomerica's Market Cap?

(NASDAQ: BMRA) Biomerica's market cap is $20.69M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biomerica's market cap is calculated by multiplying BMRA's current stock price of $1.23 by BMRA's total outstanding shares of 16,821,646.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.